Results
9
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
9 companies
ISU Abxis
Market Cap: ₩189.5b
A biopharmaceutical company, develops and markets products for the treatment of cancer and rare diseases worldwide.
A086890
₩5,130.00
7D
-1.5%
1Y
-27.5%
JW Holdings
Market Cap: ₩259.6b
Operates as a healthcare company in South Korea, the United States, Japan, China, and internationally.
A096760
₩3,715.00
7D
6.0%
1Y
27.7%
JW Lifescience
Market Cap: ₩192.0b
Provides national infusion solutions in South Korea and internationally.
A234080
₩12,400.00
7D
1.7%
1Y
2.6%
KOREA PHARMA
Market Cap: ₩158.8b
Produces pharmaceutical drugs.
A032300
₩14,560.00
7D
-0.5%
1Y
-19.0%
BioNote
Market Cap: ₩516.9b
Manufactures and sells in-vitro diagnostic animal medicines in South Korea.
A377740
₩5,100.00
7D
0%
1Y
22.3%
JW Pharmaceutical
Market Cap: ₩534.5b
Manufactures and sells medicines and medical supplies in Japan and internationally.
A001060
₩23,050.00
7D
-0.6%
1Y
-22.3%
DongKook Pharmaceutical
Market Cap: ₩765.8b
Produces and sell pharmaceutical products in South Korea and internationally.
A086450
₩17,250.00
7D
1.7%
1Y
-9.2%
Daihan PharmaceuticalLtd
Market Cap: ₩176.4b
Engages in the manufacture and sale of therapeutic drugs in South Korea.
A023910
₩30,000.00
7D
5.6%
1Y
4.5%
Oscotec
Market Cap: ₩1.1t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩28,100.00
7D
-4.7%
1Y
-25.1%